Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis

Genes Chromosomes and Cancer

Volumn 48, Issue 10, 2009, Pages 865-885

  Hodge, Jennelle C ^a,b,c   Park, Peter J ^b,d,e   Dreyfuss, Jonathan M ^d   Assil Kishawi, Iman ^f   Somasundaram, Priya ^a   Semere, Luwam G ^g   Quade, Bradley J ^a,b   Lynch, Allison M ^a   Stewart, Elizabeth A ^a,b   Morton, Cynthia C ^a,b,d,h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d LABORATORY FOR MOLECULAR MEDICINE   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f AGILENT TECHNOLOGIES   (United States)

^g HARVARD UNIVERSITY   (United States)

^h New Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BASE; MIXED LINEAGE LEUKEMIA 5 PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; ONCOPROTEIN; PROTEIN RINT 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELIC IMBALANCE; ARTICLE; CHROMOSOME 7Q; CHROMOSOME DELETION; CHROMOSOME MOSAICISM; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENOMIC INSTABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; INTERPHASE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; UBIQUITINATION; UTERINE LEIOMYOMATA; UTERUS MYOMA;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 7; COMPARATIVE GENOMIC HYBRIDIZATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEIOMYOMA; MIDDLE AGED; MOSAICISM; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; UTERINE NEOPLASMS; UTERUS;

EID: 70349320291     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20692     Document Type: Article

References (44)

1. Andersen J, DyReyes VM, Barbieri RL, Coachman DM, Miksicek RJ. 1995. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures. J Soc Gynecol Invest 2:542-551.
2. Burger AM, Seth AK. 2004. The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications. Eur J Cancer 40:2217-2229.
3. Buttram VC, Jr., Reiter RC. 1981. Uterine leiomyomata: Etiology, symptomatology, and management. Fertil Steril 36:433-445.
4. Cheng F, Liu J, Zhou SH, Wang XN, Chew JF, Deng LW. 2008. RNA interference against mixed lineage leukemia 5 resulted in cell cycle arrest. Int J Biochem Cell Biol 40:2472-2481.
5. Cheung VG, Nowak N, Jang W, Kirsch IR, Zhao S, Chen XN, Furey TS, Kim UJ, Kuo WL, Olivier M, Conroy J, Kasprzyk A, Massa H, Yonescu R, Sait S, Thoreen C, Snijders A, Lemyre E, Bailey JA, Bruzel A, Burrill WD, Clegg SM, Collins S, Dhami P, Friedman C, Han CS, Herrick S, Lee J, Ligon AH, Lowry S, Morley M, Narasimhan S, Osoegawa K, Peng Z, Plajzer-Frick I, Quade BJ, Scott D, Sirotkin K, Thorpe AA, Gray JW, Hudson J, Pinkel D, Ried T, Rowen L, Shen-Ong GL, Strausberg RL, Birney E, Callen DF, Cheng JF, Cox DR, Doggett NA, Carter NP, Eichler EE, Haussler D, Korenberg JR, Morton CC, Albertson D, Schuler G, de Jong PJ, Trask BJ. 2001. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature 409:953-958. (Pubitemid 32165355)
6. Coronado GD, Marshall LM, Schwartz SM. 2000. Complications in pregnancy, labor, and delivery with uterine leiomyomas: A population-based study. Obstet Gynecol 95:764-769.
7. Cramer SF, Patel A. 1990. The frequency of uterine leiomyomas. Am J Clin Pathol 94:435-438.
8. Dal Cin P, Van den Berghe H, Sciot R, de Wever I. 1997. Deletion of the long arm of chromosome 7 in lipoma. Cancer Genet Cytogenet 96:85-86. (Pubitemid 127738680)
9. Dal Cin P, Vanni R, Marras S, Moerman P, Kools P, Andria M, Valdes E, Deprest J, Van de Ven W, Van den Berghe H. 1995. Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res 55:1565-1568.
10. Dannenberg JH, David G, Zhong S, van der Torre J, Wong WH, Depinho RA. 2005. mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev 19:1581-1595. (Pubitemid 41003001)
11. Deng LW, Chiu I, Strominger JL. 2004. MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proc Natl Acad Sci USA 101:757-762. (Pubitemid 38121031)
12. Flynn M, Jamison M, Datta S, Myers E. 2006. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol 195:955-964. (Pubitemid 44415640)
13. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. 2004. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5:R80.
14. Hartmann KE, Birnbaum H, Ben-Hamadi R, Wu EQ, Farrell MH, Spalding J, Stang P. 2006. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol 108:930-937. (Pubitemid 44498255)
15. Hashimoto K, Azuma C, Kamiura S, Kimura T, Nobunaga T, Kanai T, Sawada M, Noguchi S, Saji F. 1995. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 40:204-208.
16. Ishwad CS, Ferrell RE, Hanley K, Davare J, Meloni AM, Sandberg AA, Surti U. 1997. Two discrete regions of deletion at 7q in uterine leiomyomas. Genes Chromosomes Cancer 19:156-160. (Pubitemid 27278802)
17. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ, Weber RJ, Haussler D, Kent WJ. 2003. The UCSC Genome Browser Database. Nucleic Acids Res 31:51-54.
18. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, Wilcox LS. 1997. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ 46:1-15.
19. Liang H, Fairman J, Claxton DF, Nowell PC, Green ED, Nagarajan L. 1998. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: Evidence for multiple critical loci. Proc Natl Acad Sci USA 95:3781-3785. (Pubitemid 28173206)
20. Lin X, Liu CC, Gao Q, Zhang X, Wu G, Lee WH. 2007. RINT-1 serves as a tumor suppressor and maintains Golgi dynamics and centrosome integrity for cell survival. Mol Cell Biol 27:4905-4916. (Pubitemid 47016140)
21. Mashal RD, Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, Morton CC, Sklar J. 1994. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 11:1-6. (Pubitemid 24273967)
22. Meloni AM, Surti U, Contento AM, Davare J, Sandberg AA. 1992. Uterine leiomyomas: Cytogenetic and histologic profile. Obstet Gynecol 80:209-217.
23. Moore SD, Herrick SR, Ince TA, Kleinman MS, Cin PD, Morton CC, Quade BJ. 2004. Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF. Cancer Res 64:5570-5577.
24. Nibert M, Heim S. 1990. Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 2:3-13.
25. Ozisik YY, Meloni AM, Surti U, Sandberg AA. 1993. Deletion 7q22 in uterine leiomyoma. A cytogenetic review. Cancer Genet Cytogenet 71:1-6.
26. Paulson KE, Rieger-Christ K, McDevitt MA, Kuperwasser C, Kim J, Unanue VE, Zhang X, Hu M, Ruthazer R, Berasi SP, Huang CY, Giri D, Kaufman S, Dugan JM, Blum J, Netto G, Wazer DE, Summerhayes IC, Yee AS. 2007. Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer. Cancer Res 67:6136-6145. (Pubitemid 47037494)
27. Ptacek T, Song C, Walker CL, Sell SM. 2007. Physical mapping of distinct 7q22 deletions in uterine leiomyoma and analysis of a recently annotated 7q22 candidate gene. Cancer Genet Cytogenet 174:116-120. (Pubitemid 46602533)
28. Quintana DG, Thome KC, Hou ZH, Ligon AH, Morton CC, Dutta A. 1998. ORC5L, a new member of the human origin recognition complex, is deleted in uterine leiomyomas and malignant myeloid diseases. J Biol Chem 273:27137-27145. (Pubitemid 28500421)
29. Rein MS, Friedman AJ, Barbieri RL, Pavelka K, Fletcher JA, Morton CC. 1991. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol 77:923-926.
30. Rein MS, Nowak RA. 1992. Biology of uterine myomas and myometrium in vitro. Semin Reprod Endocrin 10:310-319.
31. Rein MS, Powell WL, Walters FC, Weremowicz S, Cantor RM, Barbieri RL, Morton CC. 1998. Cytogenetic abnormalities in uterine myomas are associated with myoma size. Mol Hum Reprod 4:83-86. (Pubitemid 28109165)
32. Saito E, Okamoto A, Saito M, Shinozaki H, Takakura S, Yanaihara N, Ochiai K, Tanaka T. 2005. Genes associated with the genesis of leiomyoma of the uterus in a commonly deleted chromosomal region at 7q22. Oncol Rep 13:469-472.
33. Sargent MS, Weremowicz S, Rein MS, Morton CC. 1994. Translocations in 7q22 define a critical region in uterine leiomyomata. Cancer Genet Cytogenet 77:65-68. (Pubitemid 24334434)
34. Sell SM, Altungoz O, Prowse AA, Meloni AM, Surti U, Sandberg AA. 1998. Molecular analysis of chromosome 7q21.3 in uterine leiomyoma: Analysis using markers with linkage to insulin resistance. Cancer Genet Cytogenet 100:165-168. (Pubitemid 128766363)
35. Sell SM, Tullis C, Stracner D, Song CY, Gewin J. 2005. Minimal interval defined on 7q in uterine leiomyoma. Cancer Genet Cytogenet 157:67-69. (Pubitemid 40164861)
36. Smyth GK. 2005. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and computational biology solutions using R and bioconductor. New York: Springer, pp 397-420.
37. Sourla A, Polychronakos C, Zeng WR, Nepveu A, Kukuvitis A, Naud F, Koutsilieris M. 1996. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas. Cancer Res 56:3123-3128.
38. Storey JD, Tibshirani R. 2003. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100:9440-9445.
39. Suzuki H, Ouchida M, Yamamoto H, Yano M, Toyooka S, Aoe M, Shimizu N, Date H, Shimizu K. 2008. Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer. Lung Cancer 59:24-31.
40. van der Heijden O, Chiu HC, Park TC, Takahashi H, LiVolsi VA, Risinger JI, Barrett JC, Berchuck A, Evans AC, Behbakht K, Menzin AW, Liu PC, Benjamin I, Morgan MA, King SA, Rubin SC, Boyd J. 1998. Allelotype analysis of uterine leiomyoma: Localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q. Mol Carcinogen 23:243-247. (Pubitemid 29035257)
41. Vanharanta S, Wortham NC, Laiho P, Sjoberg J, Aittomaki K, Arola J, Tomlinson IP, Karhu A, Arango D, Aaltonen LA. 2005. 7q deletion mapping and expression profiling in uterine fibroids. Oncogene 24:6545-6554. (Pubitemid 41486637)
42. Vanharanta S, Wortham NC, Langford C, El-Bahrawy M, van der Spuy Z, Sjoberg J, Lehtonen R, Karhu A, Tomlinson IP, Aaltonen LA. 2007. Definition of a minimal region of deletion of chromosome 7 in uterine leiomyomas by tiling-path microarray CGH and mutation analysis of known genes in this region. Genes Chromosomes Cancer 46:451-458. (Pubitemid 46449247)
43. Xing YP, Powell WL, Morton CC. 1997. The del(7q) subgroup in uterine leiomyomata: Genetic and biologic characteristics. Further evidence for the secondary nature of cytogenetic abnormalities in the pathobiology of uterine leiomyomata. Cancer Genet Cytogenet 98:69-74.
44. Zeng WR, Scherer SW, Koutsilieris M, Huizenga JJ, Filteau F, Tsui LC, Nepveu A. 1997. Loss of heterozygosity and reduced expression of the CUTL1 gene in uterine leiomyomas. Oncogene 14:2355-2365. (Pubitemid 27260728)